| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.867 | 0.002 | 0.867 | Vasodilator | 0.325 0.04 CID_131270 | ||
| 0.735 | 0.005 | 0.735 | 5 Hydroxytryptamine release stimulant | 0.658 0.01 CID_131270 | ||
| 0.706 | 0.005 | 0.706 | Cardiotonic | |||
| 0.678 | 0.004 | 0.678 | Interleukin 1 antagonist | 0.138 0.067 CID_131270 | ||
| 0.662 | 0.009 | 0.662 | Vasodilator, peripheral | |||
| 0.587 | 0.004 | 0.587 | Interleukin 6 antagonist | 0.19 0.047 CID_131270 | ||
| 0.464 | 0.023 | 0.464 | Interleukin antagonist | |||
| 0.436 | 0.004 | 0.436 | MAP kinase 13 inhibitor | 0.104 0.075 CID_131270 | ||
| 0.423 | 0.004 | 0.423 | MAP kinase 12 inhibitor | 0.113 0.078 CID_131270 | ||
| 0.415 | 0.004 | 0.415 | Phosphodiesterase III inhibitor | |||
| 0.413 | 0.005 | 0.413 | Interleukin 1b antagonist | |||
| 0.42 | 0.014 | 0.42 | EphB2 antagonist | |||
| 0.372 | 0.017 | 0.41 | Non-steroidal antiinflammatory agent | 0.41 0.012 CID_131270 | CID_131270 | |
| 0.354 | 0.005 | 0.354 | Death-associated protein kinase 2 inhibitor | |||
| 0.337 | 0.005 | 0.337 | MAP kinase 11 inhibitor | |||
| 0.358 | 0.052 | 0.358 | Vasodilator, coronary | |||
| 0.32 | 0.015 | 0.581 | Cyclooxygenase inhibitor | 0.581 0.004 CID_131270 | CID_131270 | |
| 0.348 | 0.051 | 0.348 | Calcium channel activator | |||
| 0.281 | 0.015 | 0.52 | Cyclooxygenase 2 inhibitor | 0.52 0.004 CID_131270 | CID_131270 | |
| 0.329 | 0.066 | 0.329 | Caspase 3 stimulant | 0.268 0.098 CID_131270 | ||
| 0.351 | 0.099 | 0.351 | Histamine release inhibitor | |||
| 0.252 | 0.008 | 0.252 | MAP kinase 14 inhibitor | |||
| 0.274 | 0.045 | 0.274 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.33 | 0.114 | 0.33 | Antibacterial | |||
| 0.276 | 0.059 | 0.276 | 5 Hydroxytryptamine uptake stimulant | 0.276 0.059 CID_131270 | ||
| 0.223 | 0.008 | 0.223 | Interleukin 8 antagonist | 0.154 0.032 CID_131270 | ||
| 0.237 | 0.027 | 0.237 | Cytokine production inhibitor | |||
| 0.182 | 0.015 | 0.182 | p38 MAP kinase inhibitor | |||
| 0.258 | 0.099 | 0.337 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.337 0.042 CID_131270 | CID_131270 | |
| 0.187 | 0.039 | 0.187 | Phosphodiesterase inhibitor | |||
| 0.181 | 0.036 | 0.181 | MAP kinase kinase inhibitor | 0.144 0.055 CID_131270 | ||
| 0.175 | 0.03 | 0.175 | Antibacterial (Helicobacter pylori) | |||
| 0.201 | 0.06 | 0.201 | 5 Hydroxytryptamine 3E antagonist | 0.201 0.06 CID_131270 | ||
| 0.233 | 0.094 | 0.233 | 5 Hydroxytryptamine 1E antagonist | 0.233 0.094 CID_131270 | ||
| 0.227 | 0.095 | 0.227 | DNA damaging | |||
| 0.239 | 0.108 | 0.239 | Lipoxygenase inhibitor | |||
| 0.128 | 0.006 | 0.128 | H+/K+-transporting ATPase inhibitor | |||
| 0.212 | 0.099 | 0.212 | Tumour necrosis factor alpha release inhibitor | |||
| 0.142 | 0.035 | 0.148 | CC chemokine 6 receptor antagonist | 0.148 0.025 CID_131270 | CID_131270 | |
| 0.151 | 0.056 | 0.402 | Cyclooxygenase 1 inhibitor | 0.402 0.007 CID_131270 | CID_131270 | |
| 0.138 | 0.043 | 0.138 | GABA receptor agonist | |||
| 0.117 | 0.026 | 0.117 | GABA A receptor agonist | |||
| 0.11 | 0.023 | 0.116 | CDC25A inhibitor | 0.116 0.02 CID_131270 | CID_131270 | |
| 0.097 | 0.017 | 0.104 | CDC25B inhibitor | 0.104 0.014 CID_131270 | CID_131270 | |
| 0.117 | 0.038 | 0.117 | MAP kinase kinase 1 inhibitor | |||
| 0.147 | 0.068 | 0.147 | Cell wall synthesis inhibitor | |||
| 0.297 | 0.218 | 0.532 | Antiinflammatory | 0.532 0.075 CID_131270 | CID_131270 | |
| 0.134 | 0.058 | 0.134 | Aldehyde dehydrogenase inhibitor | 0.109 0.083 CID_131270 | ||
| 0.135 | 0.062 | 0.135 | Protein kinase (CK1) delta inhibitor | |||
| 0.076 | 0.01 | 0.076 | Neurokinin 3 antagonist | |||
| 0.08 | 0.017 | 0.08 | Neurokinin antagonist | |||
| 0.104 | 0.043 | 0.104 | 5 Hydroxytryptamine 2C antagonist | 0.089 0.053 CID_131270 | ||
| 0.155 | 0.094 | 0.155 | Tumour necrosis factor antagonist | |||
| 0.118 | 0.063 | 0.118 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.115 | 0.062 | 0.115 | 5 Hydroxytryptamine 2 antagonist | 0.085 0.084 CID_131270 | ||
| 0.123 | 0.079 | 0.123 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.07 | 0.029 | 0.078 | 5 Hydroxytryptamine 6 antagonist | 0.078 0.024 CID_131270 | CID_131270 | |
| 0.069 | 0.031 | 0.069 | Transcription factor RelA inhibitor | 0.062 0.049 CID_131270 | ||
| 0.104 | 0.07 | 0.104 | Protein kinase C gamma inhibitor | |||
| 0.065 | 0.031 | 0.073 | Alpha 1 adrenoreceptor agonist | 0.073 0.026 CID_131270 | CID_131270 | |
| 0.116 | 0.089 | 0.145 | Sodium channel (voltage-gated) blocker | 0.145 0.058 CID_131270 | CID_131270 | |
| 0.105 | 0.078 | 0.105 | CDK3/cyclin E inhibitor | |||
| 0.103 | 0.076 | 0.103 | 5 Hydroxytryptamine antagonist | |||
| 0.034 | 0.009 | 0.038 | Alpha 1a adrenoreceptor agonist | 0.038 0.008 CID_131270 | CID_131270 | |
| 0.044 | 0.019 | 0.044 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.092 | 0.068 | 0.092 | Creatine kinase inhibitor | 0.092 0.068 CID_131270 | ||
| 0.038 | 0.019 | 0.038 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.066 | 0.048 | 0.124 | Acetylcholine M5 receptor agonist | 0.124 0.01 CID_131270 | CID_131270 | |
| 0.168 | 0.151 | 0.174 | Peptidyltransferase inhibitor | 0.174 0.139 CID_131270 | CID_131270 | |
| 0.038 | 0.021 | 0.038 | ATM kinase inhibitor | |||
| 0.095 | 0.079 | 0.095 | Alpha 2b adrenoreceptor antagonist | |||
| 0.04 | 0.026 | 0.095 | Alpha 1d adrenoreceptor agonist | 0.095 0.004 CID_131270 | CID_131270 | |
| 0.02 | 0.009 | 0.02 | Alpha 2a adrenoreceptor agonist | 0.02 0.009 CID_131270 | ||
| 0.11 | 0.1 | 0.11 | Protein kinase (CK1) inhibitor | |||
| 0.063 | 0.057 | 0.063 | Glutamate (mGluR7) antagonist | 0.063 0.057 CID_131270 | ||
| 0.206 | 0.2 | 0.206 | GABA C receptor rho-3 antagonist | 0.206 0.2 CID_131270 | ||
| 0.038 | 0.032 | 0.038 | Neurokinin 2 antagonist | |||
| 0.059 | 0.054 | 0.059 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.06 | 0.058 | 0.079 | Nav1.7 sodium channel blocker | 0.079 0.034 CID_131270 | CID_131270 | |
| 0.03 | 0.031 | 0.032 | ATR kinase inhibitor | 0.032 0.026 CID_131270 | CID_131270 | |
| 0.048 | 0.05 | 0.102 | Bromodomain-containing protein 4 inhibitor | 0.102 0.013 CID_131270 | CID_131270 | |
| 0.025 | 0.029 | 0.03 | 5 Hydroxytryptamine 6 agonist | 0.03 0.017 CID_131270 | CID_131270 | |
| 0.049 | 0.054 | 0.054 | Fatty acid synthase inhibitor | 0.054 0.044 CID_131270 | CID_131270 | |
| 0.079 | 0.085 | 0.113 | MAP kinase 9 inhibitor | 0.113 0.054 CID_131270 | CID_131270 | |
| 0.073 | 0.08 | 0.094 | Caspase 7 inhibitor | 0.094 0.035 CID_131270 | CID_131270 | |
| 0.027 | 0.035 | 0.033 | Glucose-dependent insulinotropic receptor agonist | 0.033 0.026 CID_131270 | CID_131270 | |
| 0.12 | 0.129 | 0.174 | Pregnane X receptor agonist | 0.174 0.023 CID_131270 | CID_131270 | |
| 0.06 | 0.069 | 0.082 | HIV-1 integrase inhibitor | 0.082 0.036 CID_131270 | CID_131270 | |
| 0.025 | 0.046 | 0.033 | G protein-coupled receptor agonist | 0.033 0.032 CID_131270 | CID_131270 | |
| 0.046 | 0.07 | 0.078 | Cyclin D1 inhibitor | 0.078 0.02 CID_131270 | CID_131270 | |
| 0.174 | 0.198 | 0.187 | Nootropic | 0.187 0.176 CID_131270 | CID_131270 | |
| 0.04 | 0.067 | 0.05 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.05 0.042 CID_131270 | CID_131270 | |
| 0.092 | 0.128 | 0.114 | Toll-Like receptor 9 antagonist | 0.114 0.092 CID_131270 | CID_131270 | |
| 0.111 | 0.16 | 0.17 | Pyruvate kinase inhibitor | 0.17 0.1 CID_131270 | CID_131270 | |
| 0.023 | 0.072 | 0.081 | Glycine transporter inhibitor | 0.081 0.017 CID_131270 | CID_131270 | |
| 0.006 | 0.057 | 0.013 | Glucose-dependent insulinotropic receptor antagonist | 0.013 0.007 CID_131270 | CID_131270 | |
| 0.067 | 0.119 | 0.112 | Bromodomain-containing protein 2 inhibitor | 0.112 0.029 CID_131270 | CID_131270 | |
| 0.081 | 0.148 | 0.116 | Sodium channel blocker | 0.116 0.088 CID_131270 | CID_131270 | |
| 0.03 | 0.1 | 0.077 | Aldosterone antagonist | 0.077 0.012 CID_131270 | CID_131270 | |
| 0.009 | 0.08 | 0.058 | Glycine transporter 1 inhibitor | 0.058 0.013 CID_131270 | CID_131270 | |
| 0.063 | 0.135 | 0.101 | Cyclin-dependent kinase 9 inhibitor | 0.101 0.062 CID_131270 | CID_131270 | |
| 0.058 | 0.145 | 0.106 | MAP kinase 8 inhibitor | 0.106 0.054 CID_131270 | CID_131270 | |
| 0.097 | 0.19 | 0.131 | Dual specificity phosphatase inhibitor | 0.131 0.119 CID_131270 | CID_131270 | |
| 0.107 | 0.199 | 0.243 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.243 0.08 CID_131270 | CID_131270 | |
| 0.024 | 0.123 | 0.049 | mTOR inhibitor | 0.049 0.04 CID_131270 | CID_131270 | |
| 0.151 | 0.252 | 0.256 | Tyrosine 3 hydroxylase inhibitor | 0.256 0.062 CID_131270 | CID_131270 | |
| 0.033 | 0.144 | 0.053 | Alpha 1b adrenoreceptor agonist | 0.053 0.03 CID_131270 | CID_131270 | |
| 0.116 | 0.243 | 0.147 | Histone acetyltransferase inhibitor | 0.147 0.145 CID_131270 | CID_131270 | |
| 0.161 | 0.292 | 0.272 | Analgesic | 0.272 0.164 CID_131270 | CID_131270 | |
| 0.033 | 0.17 | 0.063 | Heat shock protein 90 beta antagonist | 0.063 0.036 CID_131270 | CID_131270 | |
| 0.033 | 0.179 | 0.057 | Corticotropin releasing factor 2 receptor antagonist | 0.057 0.054 CID_131270 | CID_131270 | |
| 0.074 | 0.225 | 0.122 | Transcription factor STAT6 inhibitor | 0.122 0.057 CID_131270 | CID_131270 | |
| 0.017 | 0.169 | 0.06 | Liver X receptor alpha agonist | 0.06 0.012 CID_131270 | CID_131270 | |
| 0.008 | 0.162 | 0.035 | Liver X receptor beta antagonist | 0.035 0.015 CID_131270 | CID_131270 | |
| 0.032 | 0.191 | 0.054 | Ca(v)3.2 blocker | 0.054 0.052 CID_131270 | CID_131270 | |
| 0.01 | 0.175 | 0.049 | Liver X receptor beta agonist | 0.049 0.011 CID_131270 | CID_131270 | |
| 0.026 | 0.204 | 0.071 | Leucine-rich repeat kinase 2 inhibitor | 0.071 0.068 CID_131270 | CID_131270 | |
| 0.154 | 0.353 | 0.265 | Cyclophilin D inhibitor | 0.265 0.196 CID_131270 | CID_131270 | |
| 0.07 | 0.279 | 0.155 | MAP kinase kinase 2 inhibitor | 0.155 0.117 CID_131270 | CID_131270 | |
| 0.023 | 0.241 | 0.055 | MAP kinase kinase 9 inhibitor | 0.055 0.04 CID_131270 | CID_131270 | |
| 0.02 | 0.248 | 0.048 | Cathepsin F inhibitor | 0.048 0.015 CID_131270 | CID_131270 | |
| 0.027 | 0.256 | 0.098 | Focal adhesion kinase 1 inhibitor | 0.098 0.031 CID_131270 | CID_131270 | |
| 0.008 | 0.241 | 0.061 | Liver X receptor antagonist | 0.061 0.008 CID_131270 | CID_131270 | |
| 0.034 | 0.297 | 0.069 | MAP kinase kinase 8 inhibitor | 0.069 0.046 CID_131270 | CID_131270 | |
| 0.009 | 0.312 | 0.094 | Liver X receptor agonist | 0.094 0.008 CID_131270 | CID_131270 | |
| 0.007 | 0.343 | 0.041 | Liver X receptor alpha antagonist | 0.041 0.009 CID_131270 | CID_131270 | |
| 0.061 | 0.398 | 0.191 | Thyroid hormone beta antagonist | 0.191 0.162 CID_131270 | CID_131270 | |
| 0.057 | 0.414 | 0.189 | Thyroid hormone antagonist | 0.189 0.171 CID_131270 | CID_131270 | |
| 0.01 | 0.391 | 0.428 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.428 0.005 CID_131270 | CID_131270 | |
| 0.004 | 0.399 | 0.018 | Sodium/hydrogen exchanger inhibitor | 0.018 0.01 CID_131270 | CID_131270 | |
| 0.01 | 0.666 | 0.166 | Protein-tyrosine kinase Lyn inhibitor | 0.166 0.059 CID_131270 | CID_131270 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |